May 16, 2011 - Terumo Corporation (Head Office: Shibuya-ku Tokyo; President: Yutaro Shintaku) announced the start of sale of its "Nobori" Drug-Eluting Coronary Stent (DES) in Japan from May.The product is the first made-in-Japan DES which received approval for its manufacture and sale, based on the clinical trials conducted in Japan.
"Nobori" is the only product in Japan that employs bioresorbable polymer as its drug coating material. In addition, polymer and drug are applied only to the surface to contact vessel tissues.
Terumo Corporation received CE certificate*1 for the commercial sale of the "Nobori" in Europe, in January 2008. It is currently sold in more than 20 countries in Europe, Asia (excluding Japan) and Latin America... Terumo's Press Release -
